CHALFONT ST GILES, England & PORVOO, Finland--(BUSINESS WIRE)--GE Healthcare, the healthcare business of GE (NYSE:GE) and Neste Jacobs Oy, a leading global expert in plasma fractionation plant engineering design and construction, announced today that the companies have formed a strategic alliance to assist countries worldwide to become self-sufficient in the manufacture of blood plasma products. The alliance will combine GE Healthcare’s expertise in bioprocessing for plasma fractionation with Neste Jacobs’s global bio-engineering and construction capabilities. Together, the companies will offer governments and pharmaceutical companies an integrated, cost-competitive “turn-key” approach for the construction of plasma fractionation plants, to help meet the rising worldwide demand for these potentially life-saving treatments. The alliance between the two companies aligns with GE’s healthymagination initiative, which focuses on reducing cost, increasing access and improving quality in healthcare.
